Northern Trust’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-687,426
| Closed | -$7.7M | – | 4322 |
|
|
2017
Q3 | $7.7M | Sell |
687,426
-162,203
| -19% | -$1.82M | ﹤0.01% | 2358 |
|
|
2017
Q2 | $9.35M | Buy |
849,629
+44,095
| +5% | +$485K | ﹤0.01% | 2221 |
|
|
2017
Q1 | $7.89M | Buy |
805,534
+18,609
| +2% | +$182K | ﹤0.01% | 2277 |
|
|
2016
Q4 | $8.5M | Buy |
786,925
+11,941
| +2% | +$129K | ﹤0.01% | 2220 |
|
|
2016
Q3 | $7.94M | Sell |
774,984
-2,999
| -0.4% | -$30.7K | ﹤0.01% | 2216 |
|
|
2016
Q2 | $10.2M | Buy |
777,983
+1,003
| +0.1% | +$13.1K | ﹤0.01% | 2014 |
|
|
2016
Q1 | $8.55M | Buy |
776,980
+40,162
| +5% | +$442K | ﹤0.01% | 2076 |
|
|
2015
Q4 | $6.78M | Buy |
736,818
+12,548
| +2% | +$115K | ﹤0.01% | 2260 |
|
|
2015
Q3 | $5.03M | Buy |
724,270
+67,880
| +10% | +$471K | ﹤0.01% | 2440 |
|
|
2015
Q2 | $6.45M | Buy |
656,390
+70,008
| +12% | +$688K | ﹤0.01% | 2352 |
|
|
2015
Q1 | $5.2M | Buy |
586,382
+23,647
| +4% | +$209K | ﹤0.01% | 2483 |
|
|
2014
Q4 | $4.93M | Sell |
562,735
-22,278
| -4% | -$195K | ﹤0.01% | 2519 |
|
|
2014
Q3 | $4.03M | Sell |
585,013
-42,387
| -7% | -$292K | ﹤0.01% | 2651 |
|
|
2014
Q2 | $3.3M | Sell |
627,400
-87,487
| -12% | -$460K | ﹤0.01% | 2795 |
|
|
2014
Q1 | $3.25M | Sell |
714,887
-75,579
| -10% | -$344K | ﹤0.01% | 2833 |
|
|
2013
Q4 | $3.98M | Sell |
790,466
-51,693
| -6% | -$261K | ﹤0.01% | 2716 |
|
|
2013
Q3 | $4.27M | Buy |
842,159
+1,855
| +0.2% | +$9.4K | ﹤0.01% | 2615 |
|
|
2013
Q2 | $4.17M | Buy |
+840,304
| New | +$4.17M | ﹤0.01% | 2543 |
|